Physician profile
Ryan C Chua
NPI 1659534501
$10,525.82
in general payments reported to CMS, 2019-2025
42 companies · $2,831 in 2025
The $2,831 reported for 2025 was more than what 82% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,339 · 2020: $611 · 2021: $735 · 2022: $1,199 · 2023: $1,888 · 2024: $1,922 · 2025: $2,831.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,467 · Education: $174.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,467.45 |
| Education | $174.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $2,734.61 | 2019-2025 | Fasenra, Airsupra, Tezspire |
| Glaxosmithkline, LLC. | $2,649.38 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $705.82 | 2019-2025 | Ofev, Spiriva Respimat, Stiolto Respimat |
| Regeneron Healthcare Solutions, INC. | $569.14 | 2019-2025 | Dupixent |
| Genzyme Corporation | $551.87 | 2019-2025 | |
| Actelion Pharmaceuticals US, INC. | $369.37 | 2019-2025 | Opsumit, Uptravi, Opsynvi |
| Electromed, INC. | $250.62 | 2022-2025 | Smartvest |
| Takeda Pharmaceuticals U.S.A., INC. | $188.80 | 2022-2025 | Glassia, Takhzyro |
| United Therapeutics Corporation | $185.99 | 2023-2025 | Tyvaso, Tyvaso |
| Amgen INC. | $176.93 | 2023-2025 | Tezspire |
| Mallinckrodt Hospital Products INC. | $174.72 | 2023 | Acthar |
| Novartis Pharmaceuticals Corporation | $160.32 | 2019-2024 | |
| Sanofi-Aventis U.S. LLC | $160.18 | 2020-2025 | |
| Axsome Therapeutics, INC. | $137.59 | 2023-2025 | Sunosi |
| Baxter Healthcare | $117.08 | 2024-2025 | Hillrom - Vest System Model 105 Home Care |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Chua listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.